Who is Scott Mittelstadt?
A Lifetime of Sports and Physiology
Scott was born in Storm
Lake, Iowa on May 6, 1963. His participation in sports (wrestling and
long-distance running) was what drove his interest in science and his
final decision to study physiology. He was always trying to understand
what made some athletes perform better than others. He read a lot on
training methods and diets and then would try the new training methods and
diets on himself. Although his reading and experimentation were not
always backed by the best science, they did increase his interest in
science and eventually led him to his career choice of exercise
physiology.
Sports and School
Scott attended a
small college in Iowa called Northwestern College. He chose to go there
because the school had excellent academics and allowed him to continue
running track and cross-country. While there he met a faculty member who
was very interested in sports research and reinforced his interest in that
subject. Dr. Beach took Scott to his first scientific meeting. He also
helped Scott apply to a number of graduate schools for his Master’s
degree. Scott graduated from Northwestern College with a B.A. in Biology
and a minor in Physical Education.
He chose to go to the University of Northern Iowa for
his Master’s degree, primarily due to the fact that it was in his home
town of Cedar Falls, Iowa and he was familiar with some of the faculty.
He knew that Dr. Forrest Dolgener was interested in research on
long-distance running and felt that Dr. Dolgener would be a good person to
help him begin to understand the research process. Scott’s goal was
always to finish his Master’s and then continue his graduate education at
another school. At the University of Northern Iowa, Scott was given the
opportunity to spend a large amount of time in a “real” laboratory. Since
all of the research conducted in that lab was on human subjects, the
graduate students were able to try out new techniques using each other as
subjects.
Scott then chose to go to the University of Missouri
for his Ph.D. work because Dr. Ben Londeree had conducted a number of
studies regarding distance running performance that Scott found
interesting. During his first 2 years in Missouri, Scott was involved in
a number of studies investigating performance in distance runners and
cyclists. As he began to develop some of his research questions, it
became clear that it was going to be difficult to answer these questions
in humans. At about that time, Scott attended a seminar by Dr. Harold
Laughlin (also at the University of Missouri) who described techniques he
used to assess the exercise response in rats. He was willing to let Scott
work in his lab to learn those techniques. Scott ended up conducting his
dissertation research in that lab. During his time working in Dr.
Laughlin’s lab, Scott was exposed to a lot of basic research that was not
related necessarily to exercise.
After completing his dissertation, Dr. Mittelstadt
wanted to continue his training in research on the control of the
cardiovascular system. He chose a post-doctoral fellowship at the Medical
College of Wisconsin with Drs. Phil Clifford and Leonard Bell. His
experience there was a great learning experience because it allowed him to
continue learning about research in chronically instrumented animals (now
he was working in dogs) and continue conducting research on exercise
performance in endurance athletes (cross-country skiers).
Working at a Pharmaceutical Company
After his postdoctoral training was finished, Dr.
Mittelstadt was hired by Procter & Gamble Pharmaceuticals to conduct pharmacology
studies investigating the cardiovascular effects of drugs in pre-clinical
models. The techniques he used were techniques that he learned during
graduate school and his post-doctoral fellowship.
At the present time Dr. Mittelstadt works with a
group of other scientists. The group conducts Safety Pharmacology
studies. Safety Pharmacology studies are studies that investigate the
potential undesirable pharmacological effects of a drug on physiological
function. The major organ systems they study are the cardiovascular,
respiratory, and central nervous systems. In addition, Dr. Mittelstadt
designs pre-clinical safety programs to support the clinical development
of drugs. The studies he helps plan include short-term, long-term,
reproductive, and genetic toxicity studies. The multi-organ system
physiology that he learned as an exercise physiologist is very helpful as
he tries to integrate data from many types of studies into an integrated
conclusion.
Outside Activies
Dr. Mittelstadt enjoys watching all sports. He likes
to run, hike, bike, and play golf. He is also active leading classes and
community activities at his church.
Advice for Graduate Students
Although your primary focus will be your research
project with your advisor, this is a wonderful time to get exposed to as
many people and ideas as possible. I have found that many times when I
least expect it, I meet the person who becomes a very important
collaborator. During this time you will probably meet the person you want
to conduct your postdoctoral fellowship with.
Recent Publications
1. Mittelstadt, S.W., K.P. O'Hagan, L.B. Bell, and
P.S. Clifford. Intrapericardial blocking agents have extra-cardiac effects
in dogs.
Am. J. Physiol. Regulatory Integrative Physiol. 266: R1970-R1975,
1994.
2. Mittelstadt, S.W., L.B. Bell, K.P. O'Hagan, and
P.S. Clifford. Muscle chemoreflex alters vascular conductance in
nonischemic exercising skeletal muscle.
J.
Appl. Physiol. 77:2761-2766, 1994.
3. O'Hagan, K.P., R.S. Anderson, L.B. Bell, S.W.
Mittelstadt, and P.S. Clifford. Phenylbiguanide does not inhibit
locomotion in conscious rabbits.
J. Appl. Physiol. 79:1346-1350, 1995.
4. Mittelstadt, S.W., L.B. Bell, K.P. O'Hagan, J.E.
Sulentic, and P.S. Clifford. Muscle chemoreflex causes renal vascular
constriction.
Am. J. Physiol. Heart Circ. Physiol. 270: H951-H956, 1996.
5. Mittelstadt, S.W., A.E. Maynard, D.R. Benn, E.R.
Lowe, and D.R. Kostreva. Effects of azimilide and d,l-sotalol on the heart
rate and blood pressure response to isoproterenol in anesthetized rats.
Cardiovasc. Drugs Ther. 11: 591-598, 1997.
6. Hamlin, R.D., C.A. Cruze, S.W. Mittelstadt, A.
Kijtawornrat, B.W. Keene, B.M. Roche, T. Nakayama, H. Nakayama, and D.M.
Hamlin. Sensitivity and specificity of isolated perfused guinea pig heart
to test for drug-induced lengthening of QTc. J. Pharmacol. Toxicol.
Methods 49: 15-23, 2004.
|
 |